A Multiple Myeloma Trial in Patients With Bone Metastases
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study the safety of treating patients with multiple myeloma
and at least one bone lesion with zoledronic acid 4mg intravenously (IV) every 3 - 4 weeks
for 2 years. Patients will receive a zoledronic acid infusion for 15 minutes or 30 minutes.